WO2025226842 - EXPRESSION CONTROL BY DRG-EXPRESSED MIRNAS
National phase entry is expected:
Publication Number
WO/2025/226842
Publication Date
30.10.2025
International Application No.
PCT/US2025/026016
International Filing Date
23.04.2025
Title **
[English]
EXPRESSION CONTROL BY DRG-EXPRESSED MIRNAS
[French]
CONTRÔLE D'EXPRESSION PAR DES ARNMI EXPRIMÉS PAR DRG
Applicants **
KATE THERAPEUTICS, INC.
Inventors
SESHADRI, Saurav
TABEBORDBAR, Mohammadsharif
TABEBORDBAR, Shayan
Priority Data
63/638,126
24.04.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2191 | |
| EPO | Filing, Examination, Granting | 10814 | |
| Japan | Filing, Examination, Granting | 2327 | |
| South Korea | Filing, Examination, Granting | 2360 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
22,432
Contact Us
Abstract[English]
, vectors such as viral vectors) that express a transgene and at least one binding site of at least one microRNA (miR) selected from miR-338-3p, miR-138-5p, and miR-9-5p, which selectively inhibit expression of the transgene in the dorsal root ganglia (DRG).[French]
, des vecteurs tels que des vecteurs viraux) qui expriment un transgène et au moins un site de liaison d'au moins un microARN (miR) choisi parmi miR-338-3p, miR-138-5p et miR-9-5p, qui inhibent sélectivement l'expression du transgène dans les ganglions de la racine dorsale (DRG).